question 1 (18 marks) - litfl · • raynaud’s syndrome • buerger’s disease c. list your...

10
UNIVERSITY HOSPITAL, GEELONG FELLOWSHIP WRITTEN EXAMINATION WEEK 23– TRIAL SHORT ANSWER QUESTIONS Suggested answers PLEASE LET TOM KNOW OF ANY ERRORS/ OTHER OPTIONS FOR ANSWERS Please do not simply change this document - it is not the master copy ! Question 1 (18 marks) A 35 year old man experiences a fall and sustains an isolated left wrist injury. a. State two (2) abnormal findings in these xrays. (2 marks) # distal radius- transverse, impacted , dorsal angulation, extra articular # scaphoid- waist You decide to correct the abnormality with a local anaesthetic, manipulation and plaster. b. List five (5) patient -related contraindications to the performance of this procedure. (5 marks) Refusal to consent Non compliant with procedure/ uncooperative pt Compound injury- skin breach Uncontrolled HT Allergy to prilocaine Failure to obtain IV access in dorsum hand Raynaud’s syndrome Buerger’s disease c. List your preferred drug and dose for this procedure. (2 marks) Drug: prilocaine Dose: 0.5% 1 ml/kg = max 3 mg/kg (some up to 5mg/kg) During the procedure the patient experiences a seizure. The patient is transferred to a resuscitation cubicle and is placed in the left lateral position. d. List five (5) steps in the management of this toxicity, for this patient. (5 marks) Check/ reinflate cuff Stop drug Bz Intralipid Haemodialysis e. List four (4) potential errors that may have led to the seizure. (4 marks) Cuff failure/leak Failure to inflate cuff to sufficient BP Incorrect prilocaine dose administration Incorrect medication choice- eg lignocaine Inadvertent incorrect medication “List” = 1-3 words “State”= short statement/ phrase/ clause

Upload: others

Post on 14-Nov-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Question 1 (18 marks) - LITFL · • Raynaud’s syndrome • Buerger’s disease c. List your preferred drug and dose for this procedure. (2 marks) Drug: prilocaine Dose: 0.5% 1

UNIVERSITYHOSPITAL,GEELONG

FELLOWSHIPWRITTENEXAMINATIONWEEK23–TRIALSHORTANSWERQUESTIONSSuggestedanswersPLEASELETTOMKNOWOFANYERRORS/OTHEROPTIONSFORANSWERSPleasedonotsimplychangethisdocument-itisnotthemastercopy!

Question1(18marks)A35yearoldmanexperiencesafallandsustainsanisolatedleftwristinjury.

a. Statetwo(2)abnormalfindingsinthesexrays.(2marks)

• #distalradius-transverse,impacted,dorsalangulation,extraarticular• #scaphoid-waist

Youdecidetocorrecttheabnormalitywithalocalanaesthetic,manipulationandplaster.

b. Listfive(5)patient-relatedcontraindicationstotheperformanceofthisprocedure.(5marks)• Refusaltoconsent• Noncompliantwithprocedure/uncooperativept• Compoundinjury-skinbreach• UncontrolledHT• Allergytoprilocaine• FailuretoobtainIVaccessindorsumhand• Raynaud’ssyndrome• Buerger’sdisease

c. Listyourpreferreddruganddoseforthisprocedure.(2marks) Drug:prilocaine Dose:0.5%1ml/kg=max3mg/kg(someupto5mg/kg)

Duringtheprocedurethepatientexperiencesaseizure.Thepatientistransferredtoaresuscitationcubicleandisplacedintheleftlateralposition.

d. Listfive(5)stepsinthemanagementofthistoxicity,forthispatient.(5marks)• Check/reinflatecuff• Stopdrug• Bz• Intralipid• Haemodialysis

e. Listfour(4)potentialerrorsthatmayhaveledtotheseizure.(4marks)• Cufffailure/leak• FailuretoinflatecufftosufficientBP• Incorrectprilocainedoseadministration• Incorrectmedicationchoice-eglignocaine• Inadvertentincorrectmedication

“List”=1-3words“State”=shortstatement/phrase/clause

Page 2: Question 1 (18 marks) - LITFL · • Raynaud’s syndrome • Buerger’s disease c. List your preferred drug and dose for this procedure. (2 marks) Drug: prilocaine Dose: 0.5% 1

2

Question2(12marks)

a. RegardingRheumaticfever,listthefive(5)majormanifestationsthatareincludedinthemodifiedJonescriteria.(5marks)

• Migratoryarthritis(predominantlyinvolvingthelargejoints)• Carditisandvalvulitis(eg,pancarditis)• Centralnervoussysteminvolvement(eg,Sydenhamchorea)• Erythemamarginatum• Subcutaneousnodules

b. RegardingRheumaticfever,listthefour(4)minormanifestationsthatareincludedinthemodifiedJonescriteria.(4marks)

• Arthralgia• Fever• Elevatedacutephasereactants(erythrocytesedimentationrate[ESR],C-

reactiveprotein[CRP])• ProlongedPRinterval

c. RegardingRheumaticfever,listtwo(2)investigationsthatassistwithdefinitivediagnosis.(2marks)

• ASOTtitre-rise• ThroatculturesforGroupAstrep

d. RegardingRheumaticfever,listone(1)patientgroupinAustralasiathatismostlikelytoexperiencethedisease.(1mark)

• Indigenous

Page 3: Question 1 (18 marks) - LITFL · • Raynaud’s syndrome • Buerger’s disease c. List your preferred drug and dose for this procedure. (2 marks) Drug: prilocaine Dose: 0.5% 1

3

Question3(12marks)

A35yearoldwomanpresentswithdecreasedvisioninherrighteye.

a. Whatisthediagnosisforhercondition?(1mark)

• Retinaldetachment

b. Listtwo(2)differentaetiologiesthatareassociatedwiththiscondition. (2marks)• Myopia• Cataractremoval• Oculartrauma• Vitreousdiseases• Fluoroquinoloneuse• Marfan’ssyndrome

c. Listtwo(2)featuresthatyouwouldexpectthepatienttoreportinthepatternofhervisualloss.

(2marks)• Slowonsetoverhours

o “likeashadeovertheeye”/darkcurtain/shadow• Flashesorfloaters

d. Otherthanretinalappearance,listthetwo(2)mainfeaturesthatyouwouldexpecton

examination.(2marks)• Visualfielddefect• ↓VA

ThepatientisreferredtotheOphthalmologyteam.

e. Listthree(3)managementstepsforthispatientwhileintheemergencydepartment.(3marks)

• Antiemetic(notmaxolon-↑IOP)• Padeye• Bedrest

f. Whichtwo(2)factorshavethemajorinfluenceonprognosisinthiscondition?(2marks)

• %ofretinainvolved• TimetodefinitiveRx(surgery)

Page 4: Question 1 (18 marks) - LITFL · • Raynaud’s syndrome • Buerger’s disease c. List your preferred drug and dose for this procedure. (2 marks) Drug: prilocaine Dose: 0.5% 1

4

Question4(12marks)

a. Listfive(5)factorsthatimproveadaptationtoshiftwork. (5marks)• Circadianprinciplesinrostering-clockwiseshiftrotation• Lightexposureintheworkplace• Avoidcaffeine/nicotine/alcoholnearbedtime(eachcanbe1mark)• Regularmealspromotessleep• Regularexercisepromotessleep

b. Regardingrostering,listseven(7)barrierstobestpracticerostering.(7marks)• Inadequatestaffnumbers/skillmix• Equalnightshiftallocationtoallstaff• Educationsessions• Exampreparation• Requirementformanagementmeetings• Historicalprecedent• Rostersunacceptabletostaff• Awardrestrictions• Financialpressuresinc.minimisationofovertime

ThisresourceisproducedfortheuseofUniversityHospital,GeelongEmergencystaffforpreparationfortheEmergencyMedicineFellowshipwrittenexam.Allcarehasbeentakentoensureaccurateanduptodatecontent.Pleasecontactmewithanysuggestions,concernsorquestions.DrTomReade(StaffSpecialist,UniversityHospital,GeelongEmergencyDepartment)Email:[email protected] November2017

Page 5: Question 1 (18 marks) - LITFL · • Raynaud’s syndrome • Buerger’s disease c. List your preferred drug and dose for this procedure. (2 marks) Drug: prilocaine Dose: 0.5% 1

5

Question5(10marks)

A45yearoldmanpresentswithpalpitations.Hehasnochestpain.

Onexamination:BP140/60mmHgRR20/minOxygensaturation98%on6LviaHudsonmaskGCS15

a. Listfive(5)abnormalitiesshowninthisECG.(5marks)• Irregular• BC~140msec• BeattobeatvariationinQRSduration(classically,amplitudeshouldnotvary)• Tachycardia~300• LAD• AbnormalRwaveprogressioninchestleads

b. StateaunifyingdiagnosisfortheseECGfindings. (1mark)• WPWAF

.c. List two(2)alternative,definitivetreatmentoptions for thispatient.Stateone(1) justification

foreachchoice.(4marks)• DCR

Justification:Urgentcardioversionisrequired,duetoriskofdeteriorationtoVF(despitelackofhaemodynamiccompromise)

• Flecainide Justification:Flecainideistheonlysuitabledrugchoice-slowsconductioninaccessorypathways

Page 6: Question 1 (18 marks) - LITFL · • Raynaud’s syndrome • Buerger’s disease c. List your preferred drug and dose for this procedure. (2 marks) Drug: prilocaine Dose: 0.5% 1

6

Question6(13marks)Anunknown32yearoldwomanisinvolvedinasingleoccupanthighspeed,rollovermotorcarcollision.Onarrivalsheisconfused.Herobservationsare:BP100/60mmHgsupineHR135/minRR28/minOxygensaturation92%on6LviaHudsonmaskGCS13E4V4M5

a. Listone(1)positivefindinginthisxray.(1mark)

• Advancedpregnancy

PrimarysurveyrevealsnoabnormalityincludingFASTscannegative.Secondarysurveyrevealsnolimbinjury.

b. Listthree(3)radiologicalinvestigationsthatyouwouldperform.Stateone(1)justificationforeachchoice.(6marks)

Radiologicalinvestigation Justification

CTB • GCSwithCHICXR • RR28mechanismCTCspine • DecreasedGCS

• Mechanism

c. Listthree(3)keypathologyinvestigationsthatyouwouldperforminthiscase.Stateone(1)justificationforeachchoice.(6marks)

Pathologicalinvestigation Justification

FBE • Estimationofbloodloss.• Maybeanaemicassocwithpregnancy• Pltcount-?pre-existing↓Plt

G+H • RiskofautoimmunisationKleihauer • IfRh-veBloodalcohol • Possiblecauseof↓GCSBSL • PossiblecauseforcollisionPolicebloods • ForensicdocumentationDruglevels-incparacetamol • +/-otherdrugsifaccess

• ifPHxMajorPsychiatricillnessparasuicidesUrinedrugscreen • ifPHxMajorPsychiatricillnessparasuicides

Page 7: Question 1 (18 marks) - LITFL · • Raynaud’s syndrome • Buerger’s disease c. List your preferred drug and dose for this procedure. (2 marks) Drug: prilocaine Dose: 0.5% 1

7

Question7(12marks)A49yearoldwomanpresentsviaambulancetotheEmergencyDepartment.Shehasmoderatelyseverethoracicbackpain.

a. Listfive(5)indicationsfortheperformanceofxraysofherthoracicspine.(5marks)• Trauma• Presenceofneurology• Known/suspectedmalignancy• Othermedicalconditionthatmaypredisposetopathologicalfractures-eg

Osteogenesisimperfecta• Associatedfever(especiallyifimmunocompromised/IVDU)

Reference range

Na 140 (135-145)

K 5.0 (3.5- 5.0)

Urea 28.2 (2.5- 6.4)

Creatinine 0.13 (0.05- 0.1)

Calcium 5.5 (2.1- 2.8)

Albumin 30 g/L (35-50)

AP 150 IU/L (0-120)

GGT 115 IU/L (<50)

ALT 152 IU/L (<55)

AST 125 IU/L (0-50)

Bili Total 15 µmol/L (0-19)

T. Protein 61 g/L (60-82)

b. Provideone(1)calculationtohelpyoutointerprettheseresults. (1mark)• Calculation:CorrectedCa=5.5+(40-30)x2/100=5.5+0.2=5.7

(IONIZEDCa++(corrected)=measuredCa+++(40–serumalbuming/l)x0.02)

c. Statealikelyunifyingexplanationfortheseresultsinthisclinicalcontext.Includethree(3)pointsinyouranswer.(3marks)

• Significanthypercalcaemia• Renalimpairment↑Ur:Crsuggestiveofdehydration• MildLFTabnormalitiesc/wmets• Possibledehydrationa/wmetastaticbonydisease

d. Listthree(3)keystepsinthespecifictreatmentofherbiochemicalstate. (3marks)• Rehydration-NS(notHartmannsascontainsCa)• Loopdiuretics(avoidthiazidediuretics)-maintainhighurineoutput• Bisphosphonates• Steroids• NotOestrogen(onlyinpostmenopausalprimaryhyperparathyroidism)

Page 8: Question 1 (18 marks) - LITFL · • Raynaud’s syndrome • Buerger’s disease c. List your preferred drug and dose for this procedure. (2 marks) Drug: prilocaine Dose: 0.5% 1

8

Question8(11marks) A32yearoldmanhasbeenhitinthe“groin”withacricketballthepreviousevening.Heiscomplainingofapainfulswollenscrotum.

a. Listthree(3)positivefindingsthatyoumayanticipateonaformalultrasound.Listone(1)injurythateachfindingisassociatedwith.Foreachofthesefindings,identifywhetherthefindingisanindicationforsurgicalexploration-yes/no.(9marks)

Ultrasoundfinding Injuryassociated Indicationforexploration

Parenchymalheterogeneity Intratesticularhaematoma

Yes

Lossofcontinuityoftunicaalbuginea Tunicarupture

Yes

Haematocele Testicularrupture

Yes

Noflowtotesticle Testiculartorsion

Yes

Theultrasoundisreportednormal.

b. Listyourdisposition.Stateone(1)justificationforyourchoice.(2marks)

Disposition: Admissionunderurology

Justification: Anormalultrasoundshouldnotpreventexplorationofa grosslyabnormaltesticleonphysicalexamination

Page 9: Question 1 (18 marks) - LITFL · • Raynaud’s syndrome • Buerger’s disease c. List your preferred drug and dose for this procedure. (2 marks) Drug: prilocaine Dose: 0.5% 1

9

Question9(18marks)A65yearoldmanpresentswithapainfulleftlowerleg.

a. Youareconcernedaboutthepossibilityofdeepvenousthrombosis.i. Whatistheroleofage-adjustedcut-offDDimerlevelforthispatient?Statefour(4)pointsin

youranswer.(4marks)• Recent,large,retrospectivestudyidentifiedsafetyofageadjustedcut-offs(ADJUST-PE

study-seebelow)• Ageadjustedcutoffcanbeusedifnon-highrisk• Ageinyrsx10-soadjustedcutoffis650ng/ml• Alevelbelowthiscut-off(inlow-intermediaterisk)cansafelyexcludeVTE

b. Yoususpectadiagnosisofsuperficialthrombophlebitis

i. Listfour(4)indicationsfortheperformanceoflowerlimbultrasoundforthispatient(4marks)• Involvementofupper1/3ofthigh• Clinicalevidenceofextension(>5cm)• Lowerextremityswelling>thanexpectedfromsuperficialphlebitisalone• Diagnosisuncertain

c. Anultrasoundconfirmssuperficialthrombophlebitisonly.

i. Statethree(3)indicationsforanticoagulationtherapyforthispatient.(3marks)• Affectedsegment>5cm• Thrombosisclose(<5cm)tosaphenofemoral/saphenopoplitealjunction• Presenceofmajorriskfactorforongoingthrombosis

NB:differencebetween“Minor”and“major”superficialthrombophlebitis

d. AnisolatedbelowkneeDVTisconfirmedonultrasound.i. State(2)indicationsforanticoagulationtherapyforthispatient.(2marks)NB:propagationrisksaremuchhigherinpatientswithacontinuedriskforthrombosis

• Legincylindricalimmobilisation(plaster/fibreglass)• Prothrombotichaematologicaldisorder

ii. Otherthanwarfarin,listtwo(2)anticoagulationoptionsforthispatient.(2marks)

• Clexane(enoxaparin)• Clexanefor3-5/7,followedbyDabigatran• Rivaroxaban• Apixaban

iii. Assumingthatthereisnoindicationforanticoagulationtherapy,listthree(3)stepsinyour

ongoingmanagementofthispatient.(3marks)• Aspirin• Anti-embolicstocking• RepeatUSat3-7days• Guidelinesforurgentrepresentation

Page 10: Question 1 (18 marks) - LITFL · • Raynaud’s syndrome • Buerger’s disease c. List your preferred drug and dose for this procedure. (2 marks) Drug: prilocaine Dose: 0.5% 1

10

ClickontheimagebelowtoviewtheentirePDF(&print/saveifnecessary)